Press Releases

KELOWNA, BC, Dec. 18, 2019 /PRNewswire/ - Valens GroWorks Corp. (TSXV: VGW) (OTCQX: VGWCF) (the "Company", "Valens" or "The Valens Company"), a vertically integrated provider of industry leading extraction products and services, including a diverse suite of extraction methodologies, next generation cannabinoid delivery formats and an ISO

NEW YORK, Dec. 18, 2019 /PRNewswire/ -- McCann Health has named Tim Jones as EVP, Executive Creative Director for McCann Health New York. He joins from Area 23, an

TALLAHASSEE, FL, Dec. 18, 2019 /PRNewswire/ - Trulieve Cannabis Corp. (CSE: TRUL & OTC: TCNNF) ("Trulieve" or the "Company"), a leading and top-performing cannabis company in the United States, today announced that Company founders have extended the lock-up restrictions in respect of 11,205,960 subordinate voting shares of the Co

ARLINGTON, Va., Dec. 18, 2019 /PRNewswire/ -- To help women who are pregnant or thinking of pregnancy in the New Year, March of Dimes and the U.S. Centers for Disease Control & Prevention (CDC) are partnering once again to raise awareness of the actions women can take to be a healthy mom and have a strong baby. With National Birth Defects Prevention Month

HOBOKEN, N.J., Dec. 18, 2019 /PRNewswire/ -- Autonomous Healthcare, Inc. today announced the recent publication of a research study in the

BREA, Calif., Dec. 18, 2019 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that it is now a fully independent company. The closing of Danaher Corporation's ("Danaher") exchange offer completes the journey Envista began in 2018 when its former parent company announced its intention to separate its Dental platform into one of the

SOUTH SAN FRANCISCO, Calif., Dec. 18, 2019 /PRNewswire/ -- Encoded Therapeutics, Inc. (Encoded), a precision gene therapy company, today announced the continued expansion of its senior lea

SCHAUMBURG, Ill., Dec. 18, 2019 /PRNewswire/ -- Signaling an important next step in the evolution of emergency department triage, the Emergency Nurses Association on Wednesday announc

HOUSTON, Dec. 18, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced its Rapid Acoustic Pulse ("RAP") device successfully

ROCKVILLE, Md., Dec. 18, 2019 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, today announced interim data from the first cohort of the ongoing Phase I/II trial of RGX-121 for the treatment of Mucopolysac